About Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma (NHL) is a type of cancer which affects the cells of the lymphatic system known as white blood cells. It typically occurs when lymphocytes, a type of white blood cell found in the lymph nodes, grow and multiply uncontrollably, causing swelling of the lymph nodes.
There are many different types of lymphoma however, the two most common types are Hodgkin Lymphoma and Non-Hodgkin Lymphoma.
Over 14,000 people are diagnosed with Non-Hodgkin Lymphoma each year in the UK with around 4,800 attributable deaths making it the fifth most common cancer and the most common blood cancer.
The exact cause of Non-Hodgkin Lymphoma is currently unknown. It it thought to to be more common in people with weakened immune systems.
As a charity we are committed to making a difference to the lives of those affected by this terrible disease. Since 2020 we have awarded over £21,000 in financial grants to medical researchers at The University of Southampton for the research and development into Non-Hodgkin Lymphoma.
A common symptom of lymphoma is swollen lymph nodes, in the neck , groin, collarbone, armpit or other parts of the body
Our Mission
The Karen Ingram Foundation aims to raise awareness and improve survival rates into the blood cancer Non-Hodgkin Lymphoma
Our Vision
Together with the University of Southampton, we are providing financial grants for the research and development of Non-Hodgkin Lymphoma.
Utilising a revolutionary new treatment called "immunotherapy" , the clinical cancer trials look to harness the power of the bodies immune system to detect and ultimately destroy lymphoma cancer cells.
The project is led by Professor Peter Johnson, Lymphoma Expert.